http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22897100

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Multicenter Study
endingPage 603
issn 1573-0646
0167-6997
issueIdentifier 5
pageRange 596-603
publicationName Investigational New Drugs
startingPage 596
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0cd75ac7df95d8825d6ba0a593e7462c
bibliographicCitation Mizugaki H, Yamamoto N, Murakami H, Kenmotsu H, Fujiwara Y, Ishida Y, Kawakami T, Takahashi T. Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors. Investigational New Drugs. 2016 Jul 01;34(5):596–603. doi: 10.1007/s10637-016-0371-6.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc1eecebfc4472896b77399b0bc22f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a489ce4b61f9b3116ba044d32b93ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a62ee886ddd6f0fa770480c241cf49d2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7691f5b0a8c0ede27d9ff1ff2932b19
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0787-2851
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_369aa4bb6d30acc036450d97973ed06f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2043bb6d4fda210a9555cc2d222aa2dd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6674957f70edb41029936ac06d9479e
date 2016-07-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/27363843
https://doi.org/10.1007/s10637-016-0371-6
https://pubmed.ncbi.nlm.nih.gov/PMC5007272
isPartOf https://portal.issn.org/resource/ISSN/0167-6997
https://portal.issn.org/resource/ISSN/1573-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4372
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors
discusses http://id.nlm.nih.gov/mesh/M0555734
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M000618590
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0383527
http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D060890Q000276
http://id.nlm.nih.gov/mesh/D000911Q000008
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D044466
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000911Q000627
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D009369Q000378
http://id.nlm.nih.gov/mesh/D000970Q000493
http://id.nlm.nih.gov/mesh/D000911Q000009
http://id.nlm.nih.gov/mesh/D060890Q000378
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D000970Q000009
http://id.nlm.nih.gov/mesh/D000911Q000493
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D061067
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9415
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168

Showing number of triples: 1 to 65 of 65.